Cargando…

Clinical relevance of RNA editing profiles in lung adenocarcinoma

Background: Lung adenocarcinoma (LUAD) is the most frequently occurring lung cancer worldwide, with increasing death rates. It belongs to the non-small cell lung cancer (NSCLC) type and has a strong association with previous smoking history. Growing evidence has demonstrated the significance of aden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Si, Chen, Shibin, Wang, Menghang, Guo, Bingchen, He, Yaowu, Chen, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043753/ https://www.ncbi.nlm.nih.gov/pubmed/36999050 http://dx.doi.org/10.3389/fgene.2023.1084869

Ejemplares similares

SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma
por: Huang, Hui, et al.
Publicado: (2021)

Molecular subtypes based on cuproptosis-related genes and immune profiles in lung adenocarcinoma
por: Wang, Yufei, et al.
Publicado: (2022)

Identification of Novel Prognostic Biomarkers Relevant to Immune Infiltration in Lung Adenocarcinoma
por: Xia, Zhi, et al.
Publicado: (2022)

Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas
por: Bjaanæs, Maria Moksnes, et al.
Publicado: (2014)

Comprehensive circular RNA expression profile of lung adenocarcinoma with bone metastasis: Identification of potential biomarkers
por: Cai, Ying, et al.
Publicado: (2022)

Comprehensive Profiling Reveals Distinct Microenvironment and Metabolism Characterization of Lung Adenocarcinoma
por: Li, Chang, et al.
Publicado: (2021)

Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma
por: Cai, Wenhan, et al.
Publicado: (2022)

A neutrophil extracellular traps-associated lncRNA signature predicts the clinical outcomes in patients with lung adenocarcinoma
por: Ding, Wencong, et al.
Publicado: (2022)

The Basis and Promise of Programmable RNA Editing and Modification
por: Lo, Nicholas, et al.
Publicado: (2022)

Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma
por: Gong, Quan, et al.
Publicado: (2023)

m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma
por: Li, Fangwei, et al.
Publicado: (2020)

RNA Editing and Its Roles in Plant Organelles
por: Hao, Wei, et al.
Publicado: (2021)

A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma
por: Lu, Yinliang, et al.
Publicado: (2022)

Characterization of Fatty Acid Metabolism in Lung Adenocarcinoma
por: Wang, Suyu, et al.
Publicado: (2022)

Editing of hnRNP K protein mRNA in colorectal adenocarcinoma and surrounding mucosa
por: Klimek-Tomczak, K, et al.
Publicado: (2006)

Integrated Dissection of lncRNA-miRNA-mRNA Pairs and Potential Regulatory Role of lncRNA PCAT19 in Lung Adenocarcinoma
por: Tang, Xiaomei, et al.
Publicado: (2022)

Necroptosis-related lncRNA in lung adenocarcinoma: A comprehensive analysis based on a prognosis model and a competing endogenous RNA network
por: Mao, Fuling, et al.
Publicado: (2022)

Integrated analysis of bulk and single-cell RNA-seq reveals the role of MYC signaling in lung adenocarcinoma
por: Hao, Lu, et al.
Publicado: (2022)

The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma
por: He, Wan, et al.
Publicado: (2022)

Identification and analysis of microRNA editing events in recurrent bladder cancer based on RNA sequencing: MicroRNA editing level is a potential novel biomarker
por: Qin, Jia-Xin, et al.
Publicado: (2022)

Identification of Potential Long Non-coding RNA Expression Quantitative Trait Methylations in Lung Adenocarcinoma and Lung Squamous Carcinoma
por: Wu, Xiaohong, et al.
Publicado: (2020)

A Novel circRNA–miRNA–mRNA Hub Regulatory Network in Lung Adenocarcinoma
por: Zuo, Haiwei, et al.
Publicado: (2021)

Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma
por: He, Wan, et al.
Publicado: (2022)

Analysis of Expression and Its Clinical Significance of the Secreted Phosphoprotein 1 in Lung Adenocarcinoma
por: Guo, Zixin, et al.
Publicado: (2020)

Commentary: RNA editing with CRISPR-Cas13
por: Matsoukas, Ianis G.
Publicado: (2018)

Quantifying RNA Editing in Deep Transcriptome Datasets
por: Lo Giudice, Claudio, et al.
Publicado: (2020)

Editorial: RNA editing and modification in development and diseases
por: Li, Yanqiang, et al.
Publicado: (2022)

Risk Model and Immune Signature of m7G-Related lncRNA Based on Lung Adenocarcinoma
por: Zhang, Chuanhao, et al.
Publicado: (2022)

Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma
por: Song, Jing, et al.
Publicado: (2021)

Brain Epitranscriptomic Analysis Revealed Altered A-to-I RNA Editing in Septic Patients
por: Zhang, Jing-Qian, et al.
Publicado: (2022)

Molecular Characterization and Clinical Relevance of RNA Binding Proteins in Colorectal Cancer
por: Zhang, Zhen, et al.
Publicado: (2020)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Prognostic markers of ferroptosis-related long non-coding RNA in lung adenocarcinomas
por: Mao, Kaimin, et al.
Publicado: (2023)

A Novel Risk-Score Model With Eight MiRNA Signatures for Overall Survival of Patients With Lung Adenocarcinoma
por: Wu, Jun, et al.
Publicado: (2021)

Identification of an Autophagy-Related lncRNA Prognostic Signature and Related Tumor Immunity Research in Lung Adenocarcinoma
por: Chen, Hang, et al.
Publicado: (2021)

Evaluation of Plasma Extracellular Vesicle MicroRNA Signatures for Lung Adenocarcinoma and Granuloma With Monte-Carlo Feature Selection Method
por: Chen, Xiangbo, et al.
Publicado: (2019)

Identification and Validation of a Ferroptosis-Related Long Non-coding RNA Signature for Predicting the Outcome of Lung Adenocarcinoma
por: Zheng, Zhiyuan, et al.
Publicado: (2021)

Quantitative Proteomic Profiling of Mitochondrial Toxicants in a Human Cardiomyocyte Cell Line
por: Wei, Zhengxi, et al.
Publicado: (2020)

Evaluation of the Prognostic Value of STEAP1 in Lung Adenocarcinoma and Insights Into Its Potential Molecular Pathways via Bioinformatic Analysis
por: Guo, Qiang, et al.
Publicado: (2020)

Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma
por: Jiang, Aimin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t3h04uhn1c2l6v7us5gdb8i02u